A breakthrough approach to clinical trials
We dramatically accelerate access to vital data needed by pharmaceutical companies who are seeking FDA approval for their new drugs
We’re integral in making clinical trials succeed by eliminating the human errors and inefficiencies that are often experienced in conducting clinical trials, which regularly yield to abandoned pharmaceutical pipelines.
With Elixia you can…
Combating COVID-19 with AstraZeneca
Elixia managed sites were responsible for representing the total of 47% of the enrolled minority population worldwide for Monoclonal Antibody therapy.
Extend access to advanced therapeutics throughout local communities
Elixia puts communities first through meaningful patient acquisition and education programs led by its Patient Outreach and Support Division.
Operations designed for rapid study start-up
Concerted operations across 5 Elixia divisions allow for study startup through study activation timelines to see record efficiencies.
Meet database locks sooner
Elixia has consistently led the global enrollment efforts for its last 25 trials conducted.
We’ve reinvented and refined the clinical trials management process
STUDY START-UP AND REGULATORY SUBMISSION
3-4 Days
FIRST RANDOMIZED PATIENT POST SITE ACTIVATION
1 – 2 Days
INTERNALLY DIRECTED SITE AUDIT
Within 10 Days
50% OF INITIAL ENROLLMENT GOAL, ON AVERAGE
12-16 Weeks
HOW WE DO IT —
TECHNOLOGY
Expedite trials with
the use of our advanced technology platform.
Rapid Patient Enrollment
Leverage the dashboard view to track network-wide study enrollment progress across each trial, in real-time.
Focus on Diversity and Inclusion
Enroll key populations for a comprehensive understanding of drug efficacy in real-world representative patient populations.
MULTI-DISCIPLINARY FOOTPRINT
An extensive network across the nation supporting multiple areas of healthcare.
Cardio-Renal Network
A network with 30+ years of experience specific to the Nephrology and Cardiology indications of clinical research.
Behavioral Health
The only clinical trials initiative focused on 100% inclusive behavioral health trials through a team of top Clinical Psychologists.
Infectious Disease
A rapid footprint on infectious disease trials, as seen by record-setting study startup and enrollment metrics throughout COVID-19.
WORLD-CLASS TEAM
Access top leaders across different sectors of healthcare to drive value in the clinical trials space and forge better patient outcomes
Interconectivity & Uniformity
High levels of operational consistency and access across sites help Elixia ensure expedition of startup processes and collaborative sharing of best practices across investigators and clinicians.
Constant Collaboration
The convergence of medical and scientific expertise within the Elixia umbrella allows the site network to constantly drive more enterprise value with each trial, in a progressive and nimble manner.
Specialized in clinical trials development, management, execution, and analysis throughout Phase II-IV of drug development
Clinical Trials Development & Management
Preferred Partnerships and alliances with more than 37 Pharmaceutical companies and Contract Research Organizations.
Data & Analytics
Delivery of numerically driven network feasibilities as well as insight to bridge the gap between much-needed clinical outcomes data and costly early phase II and III clinical trials.
The Elixia Experience Platform
A hybrid, patient-centric model to clinical trials that adopts the hallmarks of Centralized and Decentralized Study Conduct, to deliver on Elixia’s competitive advantages.
Fast track your clinical trial today.
From trial recruitment to vital data platforms, we offer the most efficient, fastest-to-market solution.